Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001827635-26-000019
Filing Date
2026-05-12
Accepted
2026-05-12 17:06:31
Documents
60
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mane-20260331.htm   iXBRL 10-Q 1300982
2 EX-31.1 exhibit311certification.htm EX-31.1 9079
3 EX-31.2 exhibit312certification.htm EX-31.2 9151
4 EX-32.1 exhibit321certification.htm EX-32.1 5899
5 EX-32.2 exhibit322certification.htm EX-32.2 5920
  Complete submission text file 0001827635-26-000019.txt   5629995

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mane-20260331.xsd EX-101.SCH 35227
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mane-20260331_cal.xml EX-101.CAL 58833
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mane-20260331_def.xml EX-101.DEF 186442
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mane-20260331_lab.xml EX-101.LAB 511359
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mane-20260331_pre.xml EX-101.PRE 356222
64 EXTRACTED XBRL INSTANCE DOCUMENT mane-20260331_htm.xml XML 513411
Mailing Address 470 JAMES STREET NEW HAVEN CT 06513
Business Address 470 JAMES STREET NEW HAVEN CT 06513 228.372.3376
Veradermics, Inc (Filer) CIK: 0001827635 (see all company filings)

EIN.: 843304423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-43097 | Film No.: 26969735
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)